The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05409066
Brief Title: Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma (EPCORE FL-1)

First Submitted : June 3, 2022
First Submitted that Met QC Criteria : June 3, 2022
First Posted : June 8, 2022

Last Update Submitted that Met QC Criteria : May 6, 2024
Last Update Posted : May 7, 2024